• 1
    Rothwell BR, Haglund W, Morton TH. Prevention and treatment of the orofacial complications of radiotherapy. J Am Dent Assoc 1987; 114: 316-22.
  • 2
    Budihna M, Skrk J, Smid L, Furland L. Tumor cell repopulation in the rest interval of split-course radiation treatment. Strahlenther Onkol 1980; 156: 402-8.
  • 3
    Trott KR. Cell population and overall treatment time. Int J Radiat Oncol Biol Phys 1990; 19: 1071-5.
  • 4
    Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-6.
  • 5
    Parsons JT, Bova FJ, Million RR. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1980; 6: 1645-52.
  • 6
    Awwad HK, Khafagy Y, Barsoum M, Ezzat S, el-Attar I, Farag H, et al. Accelerated versus conventional fractionation in the postoperative radiation of locally advanced head and neck cancer: influence on patient tumor proliferation. Radiother Oncol 1992; 25: 261-6.
  • 7
    Amdur RS, Parsons JT. Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1989; 17: 279-85.
  • 8
    Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, et al. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence of accelerated proliferation from Radiation Therapy Oncology Group protocol 8313. Cancer 1992; 69: 2744-8.
  • 9
    Overgaard J, Hjelm-Hansen M, Johansen LV, Andersen AP. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147-52.
  • 10
    Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457-63.
  • 11
    Pajak TF, Laramore GE, Marcial VA, Fazekas JT, Cooper J, Rubin P, et al. Elapsed treatment days--a critical time for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991; 20: 13-20.
  • 12
    Maciejewski B, Preuss-Bayer G, Trott KR. Head and neck tumors: decreased local control by elongation of treatment time. Int J Radiat Oncol Biol Phys 1983; 9: 321-8.
  • 13
    Spijkervet FK, Vermey A, Panders AK. Prevention of irradiation mucositis in head and neck cancer patients. Proc Am Soc Clin Oncol 1990; 9: 174.
  • 14
    Spijkervet FK, Van Saene HK, Van Saene JJ, Panders AK, Vermey A, Mehta DM, et al. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 1991; 46: 167-73.
  • 15
    Foote RL, Loprinzi CL, Frank AR, O'Fallon JR, Gulavita S, Tewfik HH, et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 1994; 12: 2630-3.
  • 16
    Spijkervet FK, Van Saene HK, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 1989; 18: 167-71.
  • 17
    O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079-87.
  • 18
    Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 1988; 39: 291-4.
  • 19
    Ferretti GA, Ash RC, Brown AT, Parr MD, Romond EH, Lillich TT. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine gluconate oral rinse. Bone Marrow Transplant 1988; 3: 483-93.
  • 20
    Symonds RP, McIlroy P, Khorrami J, Paul J, Pyper E, Lindemann E, et al. The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br J Cancer 1996; 74: 312-7.